FIELD: medicine. SUBSTANCE: preparation has Klopidogrel and Aspirin as active agent introduced in unbound state or as pharmaceutically acceptable salts. Molar proportion of Aspirin/Klopidogrel is equal to 2.5 to 11.5. Klopidogrel and Aspirin are administered as oral or parenteral applications. EFFECT: enhanced effectiveness of treatment; improved synergetic action. 13 cl, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIPLATELET AND ANTIATHEROGENIC PHARMACEUTICAL COMPOSITION CONTAINING THIENEPYRIDINE DERIVATIVE AND INHIBITOR OF HMG-COA-REDUCTASE | 1997 |
|
RU2176504C2 |
| COMPOSITION USED FOR TREATMENT AND PROPHYLAXIS OF ARTERIAL THROMBOSIS AND USAGE OF FACTOR XA INHIBITOR ALONE AND/OR IN COMBINATION WITH AGENT INHIBITING PLATELET AGGREGATION | 1998 |
|
RU2212886C2 |
| DERIVATIVES OF SUBSTITUTED 4-PHENYLTHIAZOLES, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1995 |
|
RU2124515C1 |
| PHARMACEUTICAL COMBINATIONS | 2000 |
|
RU2242232C2 |
| ANTITHROMBOTIC COMPOUND | 2012 |
|
RU2604733C2 |
| METHODS OF TREATING OR PREVENTING THROMBOSIS OR EMBOLISM | 2011 |
|
RU2611662C2 |
| AGENT FOR INHIBITION OF PLATELET AGGREGATION | 1994 |
|
RU2122853C1 |
| COMPOSITION "ANGIONORM" ELICITING ANTI-AGGREGATING, CAPILLARY-PROTECTING AND VEIN-TONIC EFFECT | 2003 |
|
RU2241483C1 |
| AGENT SHOWING ANTIAGGREGANT AND ANTITHROMBOGENIC ACTIVITY | 2010 |
|
RU2453312C1 |
| PHARMACEUTICAL COMBINATION POSSESSING ANTIAGGREGANT AND LIPID-REGULATING ACTIVITIES, PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2461379C2 |
